Buy or sell Ro stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Ro Stock
Ro is a mission-driven healthcare technology company that handles everything from online diagnosis to the delivery of medication.
About Ro Stock
Ro is a mission-driven healthcare technology company working to reinvent the way the healthcare system works. It has two verticals: Roman, an end-to-end service for men's health starting with erectile dysfunction, often the first sign of a far more serious underlying health condition, and Zero, an end-to-end service to help people quit smoking, the leading cause of preventable death worldwide.
Investors
Funding History
| October 2017 | $3.1M |
|---|---|
| August 2018 | $20.0M |
| August 2018 | $3.7M |
| August 2018 | $40.0M |
| June 2019 | $85.5M |
| July 2020 | $33.7M |
| July 2020 | $39.8M |
| July 2020 | $50.7M |
| March 2021 | $510M |
| January 2022 | $100.0M |
Management
Investor
Peter Boyce II
Co-Founder
Zachariah Reitano
Co-Founder
Saman Rahmanian
Senior Technical Program Manager
Chloe Pi
Co-Founder
Rob Schutz
CTO
Jeffrey Yang
Press
Wall Streets Journal - Jul, 28 2020
Forbes - Mar, 26 2020
Fast Company - Mar, 20 2020
Fast Company - Mar, 20 2019
TechCrunch - Oct, 23 2018
TechCrunch - Sep, 18 2018
Fast Company - Sep, 18 2018
TechCrunch - Nov, 1 2017
TechCrunch - Nov, 1 2017
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
